STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Apr 3, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The STEPS trial is studying whether e-cigarettes, or nicotine vapes, can help people who smoke and are receiving treatment for substance use disorders (SUD) quit smoking. The trial compares the effectiveness of e-cigarettes to FDA-approved medications like nicotine patches and lozenges. If you participate, the study will last for 6 months and involve five in-person visits and eleven virtual check-ins. You will also keep a short daily diary on your phone for the first twelve weeks to track your progress.
To join the trial, you must be at least 21 years old, smoke at least 5 cigarettes a day for the past six months, and be within 30 days of starting an SUD treatment program. You should also have tried to quit smoking before and want to either quit or switch to a less harmful product. However, if you are pregnant, have certain medical issues, or are already using smoking cessation medications, you won't be eligible. This study is taking place at three outpatient treatment centers in South Carolina, and it aims to find better ways to help people quit smoking while they manage their substance use disorders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 21+ years of age,
- • Smoke at least 5 cigarettes per day regularly for the past 6 months,
- • Be within 30 days of SUD treatment program admission,
- • Must submit a breath CO sample of ≥ 7 parts per million at screening and a positive instant-read urinary cotinine test (metabolite of nicotine, cut off of 200 ng/ml),
- • Have had at least one failed quit attempt in their lifetime, and
- • Have interest in reducing smoking, quitting smoking, or switching to a less harmful product.
- Exclusion Criteria:
- • Any significant or unstable medical or psychiatric concern that would affect safety,
- • Current use of pharmacotherapy for smoking cessation,
- • Pregnant, breastfeeding, or trying to become pregnant,
- • Contraindicated for NRT, and
- • Currently using an ENDS on 20+ days out of the past 30.
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pickens, South Carolina, United States
Conway, South Carolina, United States
Charleston, South Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported